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Atrial Defibrillation Using a Unipolar, Single lead
Right Ventricular to Pectoral Can System
Jeanne E. Poole. Peter J. Kudenchuk, G. Lee Dolack. Gregory K. Jones, Marye
J. Gleva. Merritt H. Raitt. George Johnson, Rahul Mehra. Luc Mongeon. Gust
H. Bardy. University of Washington, Seattle, WA
Background; The active can, unipolar right ventricular(RV)single lead system
has been shown to be very effective for ventricular defibrillation using an RV+
..... CAN- biphasic pulsing configuration. If this same RV+ ..... CAN- unipo-
lar system could perform double-duty, providing atrial as well as ventricular
defibrillation, it would broaden the role of current implantable cardioverter-
defibrillators (ICDs). It would provide an atriallCD without multiple shock elec-
trodes, simultaneously providing backup protection for inadvertent induction
of ventricular fibrillation (VF) following atrial defibrillation.
Methods and Results; The pu rpose of this study was to determ ine the RV+
..... CAN- atrial defibrillation threshold at the time of ICD surgery for 10 VTNF
patients using the Medtronic 7219C ICD shell with a biphasic 65% tilt, 60 IlF
capacitance pulse delivered one minute following induction of AI' Initial pulse
strength was 100 V and was incremented in 100 V steps every minute if atrial
fibrillation persisted. The atrial defibrillation threshold data with the RV+ .....
CAN- system were 8.3 ± 4.1 joules, 511 ± 128 volts, and 58 ± 8 ohms.
Conclusions,' Although the RV+ ..... CAN- lead system does not provide
atrial defibrillation at energies likely to be painless (e.g., <0.2J), the safety
and simplicity of this system has advantages that must be considered when
compared to more complicated two and three lead elegtrode systems. If de-
tection algorithms for AF, using near and far field electrogram analysis prove
accurate, such a simple lead system may prove c1inicallyviable.
Is Coronary Revascularization Complete Therapy
for Secondary Prevention of Ischemic Cardiac
Arrest?
Emile G. Daoud. Mark Niebauer, William H. Kou, K. Ching Man. Theresa Davidson.
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Effects of Digoxin on Ventricular Vulnerability
During Atrial Defibrillation via Implanted
Transvenous Catheter Electrodes in the Sterile
Pericarditis Model
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Western ReseNe University. Cleveland. OH
digoxin
Objectives Because digoxin is often used in patients with atrial fibrillation. we
evaluated its effects on the relative risk of inducing ventricular tachyarrhyth-
mia (VTNF) during synchronized atrial defibrillation shocks delivered through
implanted transvenous catheter electrodes.
Methods. Sterile pericarditis was created in 10 mongrel dogs. Two catheter
electrodes with a 6 cm coil tip were inserted through the right external jugular
vein and placed in the distal coronary sinus and in the right atrial appendage.
To systematically achieve variable preceding ventricular coupling intervals
(VCls). the ventricles were paced during sinus rhythm before delivery of the
atrial shock in two protocols: 1) rapid pacing (8 stimuli, S1 S, protocol); and
21 double extra stimuli (long-short intervalsl following 8 basic stimuli (S, S2S3
protocol). The VCI (S, S1 or S2S3)was shortened by 10 ms until the ventricular
effective refractory period was achieved. After sensing the last paced ventric-
ular beat. an atrial shock was delivered with a 2 ms delay at a shock intensity
of 300 V (3.2-3.6 J). i.e.. maximum shock intensity ofthe device. Atrial shocks
were delivered 4 times at each VCI in each protocol. VCI was normalized by
subtracting the OT interval in the surface ECG from the actual VCI. The rela-
tionship between the VCI and induction of VTNF was evaluated in the drug
free state and after administration of a therapeutic (50 Ilg!kg. 5 dogs) or toxic
(to obtain toxic arrhythmia. 5 dogs) dose of digoxin.
Results. Data are shown in mean ± SD. for each protocol (S, S, or S1 S2S3).
To calculate a 99% probability of sinus rhythm (SR) after an atrial shock.logis-
tic regression was used. No significant difference was observed before and
after digoxin administration. The longest VCI that preceded VTNF induction
was OT + 50 ms (290 ms) before digoxin and OT + 50 ms (310 ms) after
digoxin.
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Conclusions. Digoxin did not significantly change the risk of VTNF induc-
tion during atrial defibrillation shocks delivered through transvenous catheter
electrodes at maximum shock intensity. Shocks delivered at VCls longer than
310 ms resulted in no VTNF induction.
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Noninvasive Predictors of Successful
Implantation of Transvenous Defibrillator lead
Systems
Erica D. Engelstein. Rebecca 1. Hahn, Kenneth M. Stein. Bruce 8. Lerman. New
York Hospital-Cornell University Medical Center, New York, NY
Successful implantation of transvenous defibrillator lead systems depends
on achieving an intraoperative defibrillation threshold (DFT) of ::s25 J. Since
defibrillation is related to a critical mass of myocardium, we sought to deter-
mine whether left ventricularlLV) mass or LV volume could predict successful
*p value> 0.05
No clinical characteristic was statistically different between patients with
and without ICD shocks. In conclusion, coronary revascularization alone may
be inadequate therapy for survivors of sudden cardiac arrest associated with
ischemia who are noninducible with programmed stimulation, and clinical
variables cannot predict which patients are likely to experience recurrent ma-
lignant ventricular arrhythmias. Therefore, ICD therapy should be considered
in these patients.
Clinical Characteristics:
Coronary revascularization has been suggested assole therapy for secondary
prevention of sudden cardiac arrest associated with ischemia. Among 412
consecutive patients receiving an implantable defibrillator (ICD), 23 (6%)
were identified as: sudden cardiac arrest survivors, noninducible with pro-
grammed stimulation, unstable angina or ischemia on a functional study, and
underwent successful coronary revascularization. In follow-up, 10 (43%) of
the 23 patients received ICD shocks (8 ± 8 per patient, range: 1-22) shocks)
and 9/10 had syncopelpresyncope associated with at least one ICD dis-
charge.
Follow-up (months)
Age Iyears)
Male gender
Mean left ventricular ejection fraction (%)
Previous history of a myocardial infarction
Presence of a left ventricular aneurysm
Q·wave infarction pattern on electrocardiogram
Sudden cardiac arrest presenting with exertion,
angina, or CPK elevation
Mean number of vessels with coronary disease
Mean severity of coronary stenosis (%)
Coronary revascularization considered complete
Ii-blocker therapy
Antiarrhythmic therapy
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Internal Atrial Defibrillation: Need for
Concomitant Pacemaker Therapy and Its Effect
on Pacemaker Function
Atul Prakash. Ryszard B. Krol, Irakli Giorgberidze, Philip Mathew, Luc Mongeon.
Nadeem Haque. Sankar Varanasi, Sanjeev Saksena. Eastern Heart Institute, Passaic &
UMDNJ Medical School, Newark, NJ
Implantable defibrillators are being considered as a therapeutic option for the
chronic management of atrial fibrillation (AF). The need for concomitant pace-
maker therapy and the effect on existing pacemaker function of internal atrial
defibrillation (lAD) shocks is unknown. 21 pts, mean age 67 ± 11 yrs, mean LA
diameter 43 ± 7 mm, mean LV ejection fraction 36.5 ± 15%, underwent lAD
for drug refractory AI' 7 pts had existing WIR pacemakers. Lead configura-
tions tested for lAD using a step up protocol were RV-RA. RV-SVC, RV-axillary
patch, RA-Ieft pulmonary artery (LPA) or RA-coronary sinus (CS). RA-LPA or
CS were preferred for pts with pacemakers. Results; Of 178 biphasic shocks
delivered with energies of 1 to 20J, 36 were successful in cardioverting AF
and these were analyzed. R-R interval preceding the successful shock ranged
from 200 to 1000 ms. Mean time to the first post shock ORS was 1076 ± 368
ms (vs mean proshock R-R interval of 780 ± 18 ms, p = 0.005) and the mean
first sinus cycle length of 168 ± 490 ms (vs 780 ± 18 ms preshock R-R inter-
val. p < 0.005). Significant post shock bradycardias occurred in 6 pts (28%). 1
pt had sinus arrest with third degree AV block lasting for 7.5s. 2 pts had third
degree AV block requiring ventricular pacing support. 3 pts had post shock
pauses >2s with 1 pt having a persistent sinus cycle of 2.5s for 6s. There
was no correlation between energy used, lead configurations and the inci-
dence of bradycardias. The 7 pts with existing WIR pacemakers were suc-
cessfullycardioverted using the RA-LPA orCS configuration at a mean energy
of 9.81 ± 8.6J. There was no effect of lAD using the RA-LPA or CS configura-
tion on pacemaker function. Conclusions; 1. Pts undergoing lAD may have a
transient bradycardia following successful cardioversion which may require
backup concomitant ventricular pacing. 2. lAD can be performed safely in pts
with existing pacemakers using RA-LPA or CS lead configurations without
affecting pacemaker function at the energy levels tested. 3. An implantable
atrial defibrillator should incorporate concomitant ventricular pacing
support.
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